PMDA inspection

Novartis Pharma Schweizerhalle AG

PMDA inspection 5130608023799 · Switzerland · Suitable

Key facts

Control number 5130608023799
Manufacturing site Novartis Pharma Schweizerhalle AG
Location Rothausstrasse, 4133 Pratteln, Switzerland
Country Switzerland
Product type Pharmaceuticals
Application type Regular
Inspection method Remote
Inspection month Nov 1, 2024
Result Suitable
Result notified Dec 24, 2024
PMDA registration AG21500065

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)